On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global Blood Safety issued a new document titled ‘Points to consider in the preparation and transfusion of COVID-19 convalescent plasma.’

The document indicates that following the donation of the convalescent plasma, the use of a licensed pathogen inactivation technology is ﾓhighly desirable to reduce the risk of transfusion transmitted infections and alleviate concerns about ﾓpossible superinfections with SARS-CoV-2′.